Is this you? Create Your Porfile
Avatar

Nissen Jeffrey Scott

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Nissen Jeffrey Scott is active.

Explore More

Publication

Featured researches published by Nissen Jeffrey Scott.

Archive | 1998

IN POSITION 5-SUBSTITUTED 3-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)INDOLE AND 3-(PIPERIDIN-4-YL)INDOLE, AS WELL AS PHARMACEUTICAL COMPOSITION CONTAINING THEREOF

Audia James Edmund; Dressman Bruce Anthony; Droste James Joseph; Fritz James Erwin; Kaldor Stephen Warren; Koch Daniel James; Krushinski Joseph Herman; Thompson Dennis Charles; Nissen Jeffrey Scott; Rocco Vincent Patrick; Schaus John Mehnert

Archive | 2007

LACTAMVERBINDUNG ZUR HEMMUNG DER FREISETZUNG ODER DER SYNTHESE VON BETA-AMYLOIDPEPTID

Audia James Edmund; John Varghese; Latimer Lee H; Mcdaniel Stacey Leigh; Nissen Jeffrey Scott; Thorsett Eugene D; Tung Jay S

Archive | 2007

Lactamforbindelser til inhibering af beta-amyloidpeptidfrigivelse eller - syntese

John Varghese; Audia James Edmund; Thorsett Eugene D; Latimer Lee H; Mcdaniel Stacey Leigh; Nissen Jeffrey Scott; Tung Jay S

Archive | 2007

COMPUESTO DE LACTAMA PARA INHIBIR LA LIBERACION O SINTESIS DE PEPTIDO BETA-AMILOIDE.

Audia James Edmund; John Varghese; Latimer Lee H; Mcdaniel Stacey Leigh; Nissen Jeffrey Scott; Thorsett Eugene D

Archive | 2007

Laktamforbindelse samt farmasoytisk sammensetning inneholdende denne

Nissen Jeffrey Scott; John Varghese; Latimer Lee H; Thorsett Eugene D; Tung Jay S; Mcdaniel Stacey Leigh; Audia James Edmund

Archive | 2004

Lactam compound for inhibiting beta-amyloid and treating Alzheimer's disease

Audia James Edmund; John Varghese; Latimer Lee H; Mcdaniel Stacey Leigh; Nissen Jeffrey Scott; Thorsett Eugene D; Tung Jay S

Archive | 2003

AGONISTAS DE 5-HT1F PARA TRATAR LA MIGRAÑA.

Audia James Edmund; Nissen Jeffrey Scott

Archive | 2003

Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto

Audia James Edmund; John Varghese; Latimer Lee H; Mcdaniel Stacey Leigh; Nissen Jeffrey Scott; Thorsett Eugene D; Tung Jay S

Archive | 2003

LACTAM COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE OF IT FOR PRODUCING PHARMACEUTICAL COMPOSITION

Audia James Edmund; John Varghese; Latimer Lee H; Mcdaniel Stacey Leigh; Nissen Jeffrey Scott; Thorsett Eugene D; Tung Jay S

Archive | 2003

Lactam compound for inhibition of beta-amyloid peptide release or synthesis

Audia James Edmund; John Varghese; Latimer Lee H; Mcdaniel Stacey Leigh; Nissen Jeffrey Scott; Thorsett Eugene D; Tung Jay S

Explore More

Collaboration

Dive into the Nissen Jeffrey Scott's collaboration.

Top Co-Authors
Avatar

Audia James Edmund

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Rocco Vincent Patrick

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Krushinski Joseph Herman

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Schaus John Mehnert

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

John Varghese

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Latimer Lee H

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Mcdaniel Stacey Leigh

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Thorsett Eugene D

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Tung Jay S

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Koch Daniel James

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge